Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARECYCLINE vs SARILUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARECYCLINE vs SARILUMAB: Safety Overview

Metric SARECYCLINE SARILUMAB
Total FAERS Reports 134 21,493
Deaths Reported 0 1,983
Death Rate N/A 9.2%
Hospitalizations 11 3,538
Average Patient Age 29.1 yrs 57.5 yrs
% Female Patients 53.5% 84.4%
FDA Approval Date Oct 1, 2018 N/A
Manufacturer Almirall, LLC Sanofi-Aventis U.S. LLC
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription